Patents by Inventor Manju Sharma

Manju Sharma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240181008
    Abstract: The present invention generally relates to uses of glial cell line-derived growth factor (GDNF) in cutaneous wound healing and hair growth. Methods of effecting hair growth and/or wound healing which feature administration of GDNF, or a biologically active fragment thereof, to subjects, e.g., human subject, are disclosed herein. The invention relates also to formulations and kits for achieving the indicated pharmaceutical advantages.
    Type: Application
    Filed: December 5, 2023
    Publication date: June 6, 2024
    Applicant: The Jackson Laborartory
    Inventors: Robert E. Braun, Manju Sharma
  • Patent number: 11890322
    Abstract: The present invention generally relates to uses of glial cell line-derived growth factor (GDNF) in cutaneous wound healing and hair growth. Methods of effecting hair growth and/or wound healing which feature administration of GDNF, or a biologically active fragment thereof, to subjects, e.g., human subject, are disclosed herein. The invention relates also to formulations and kits for achieving the indicated pharmaceutical advantages.
    Type: Grant
    Filed: July 13, 2021
    Date of Patent: February 6, 2024
    Assignee: The Jackson Laboratory
    Inventors: Robert E. Braun, Manju Sharma
  • Publication number: 20220062381
    Abstract: The present invention generally relates to uses of glial cell line-derived growth factor (GDNF) in cutaneous wound healing and hair growth. Methods of effecting hair growth and/or wound healing which feature administration of GDNF, or a biologically active fragment thereof, to subjects, e.g., human subject, are disclosed herein. The invention relates also to formulations and kits for achieving the indicated pharmaceutical advantages.
    Type: Application
    Filed: July 13, 2021
    Publication date: March 3, 2022
    Applicant: The Jackson Laboratory
    Inventors: Robert E. Braun, Manju Sharma
  • Publication number: 20200147174
    Abstract: The present invention generally relates to uses of glial cell line-derived growth factor (GDNF) in cutaneous wound healing and hair growth. Methods of effecting hair growth and/or wound healing which feature administration of GDNF, or a biologically active fragment thereof, to subjects, e.g., human subject, are disclosed herein. The invention relates also to formulations and kits for achieving the indicated pharmaceutical advantages.
    Type: Application
    Filed: June 25, 2019
    Publication date: May 14, 2020
    Inventors: Robert E. BRAUN, Manju SHARMA
  • Publication number: 20190307846
    Abstract: The present invention generally relates to uses of glial cell line-derived growth factor (GDNF) in cutaneous wound healing and hair growth. Methods of effecting hair growth and/or wound healing which feature administration of GDNF, or a biologically active fragment thereof, to subjects, e.g., human subject, are disclosed herein. The invention relates also to formulations and kits for achieving the indicated pharmaceutical advantages.
    Type: Application
    Filed: June 25, 2019
    Publication date: October 10, 2019
    Inventors: Robert E. BRAUN, Manju SHARMA
  • Patent number: 10376562
    Abstract: The present invention generally relates to uses of glial cell line-derived growth factor (GDNF) in cutaneous wound healing and hair growth. Methods of effecting hair growth and/or wound healing which feature administration of GDNF, or a biologically active fragment thereof, to subjects, e.g., human subject, are disclosed herein. The invention relates also to formulations and kits for achieving the indicated pharmaceutical advantages.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 13, 2019
    Assignee: The Jackson Laboratory
    Inventors: Robert E. Braun, Manju Sharma
  • Patent number: 9719028
    Abstract: A method for predicting selective performance of an adsorbent is disclosed. The adsorbent is selected from a list of metals and/or metal cations for use in removing contaminants as thiophene derivatives in hydrocarbon feed. The metals or metal cations are identified from a list having a positive value for Erel, wherein the metal or metal cation having the largest value for Erel is the most selective adsorbent.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: August 1, 2017
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, CHEVRON U.S.A. INC.
    Inventors: Alexis T. Bell, Manju Sharma, Berend Smit, Bi-Zeng Zhan, Alice Zunqing He
  • Publication number: 20160022773
    Abstract: The present invention generally relates to uses of glial cell line-derived growth factor (GDNF) in cutaneous wound healing and hair growth. Methods of effecting hair growth and/or wound healing which feature administration of GDNF, or a biologically active fragment thereof, to subjects, e.g., human subject, are disclosed herein. The invention relates also to formulations and kits for achieving the indicated pharmaceutical advantages.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Inventors: Robert E. BRAUN, Manju SHARMA
  • Publication number: 20120232863
    Abstract: A method for predicting selective performance of an adsorbent is disclosed. The adsorbent is selected from a list of metals and/or metal cations for use in removing contaminants as thiophene derivatives in hydrocarbon feed. The metals or metal cations are identified from a list having a positive value for Erel, wherein the metal or metal cation having the largest value for Erel is the most selective adsorbent.
    Type: Application
    Filed: March 9, 2012
    Publication date: September 13, 2012
    Applicants: Chevron U.S.A. Inc., The Regents of the University of California
    Inventors: Alexis T. BELL, Manju Sharma, Berend Smit, Bi-Zeng Zhan, Alice Zunqing He